00

Guiyang Xintian Pharmaceutical Co LtdSHE 002873 Stock Report

Last reporting period 30 Jun, 2024

Updated 19 Sep, 2024

Last price

Market cap $B

0.275

Micro

Exchange

XSHE - Shenzhen Stock Exchange

002873.SZ Stock Analysis

00

Uncovered

Guiyang Xintian Pharmaceutical Co Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

28/100

Low score

Market cap $B

0.275

Dividend yield

0.85 %

Shares outstanding

227.53 B

Guiyang Xintian Pharmaceutical Co., Ltd. engages in the production, sale, research and development of Chinese medicines. The company is headquartered in Guiyang, Guizhou and currently employs 1,019 full-time employees. The company went IPO on 2017-05-19. The firm manufactures its products in the forms of capsules, mixture, granules, syrup, gel and tablets. The Company’s main products include Ningmitai Capsule, Kuntai Capsule, Kushen Gel and Xiaokucao Oral Liquid .The Company distributes its products in the domestic market.

View Section: Eyestock Rating